Fenne Smits,Kaz Groen,Mark‐David Levin,Claudia A.M. Stege,Roel J.W. van Kampen,Ellen van der Spek,Yavuz M. Bilgin,Noortje Thielen,Inger S. Nijhof,Inge Ludwig,Esther G.M. De Waal,Yorick Sandberg,Alain Kentos,Gert-Jan Timmers,Josien C. Regelink,Matthijs Westerman,Koen de Heer,Marie‐Christiane Vekemans,Nazik Durdu-Rayman,Nicole C.H.P. de Graauw
Abstract The level of frailty, according to the International Myeloma Working Group frailty index, is highly dynamic during antimyeloma treatment. Dynamic frailty assessment improved the prediction of survival and early mortality compared with the prognostic value of static frailty level at baseline.